Skip to main content

. 1992 Aug;55(8):738. doi: 10.1136/jnnp.55.8.738

HAM/TSP attributable to blood transfusion.

S Tokudome, H Shibasaki, Y Itoyama, H Shoji, T Nakamura, T Miyoshi, Y Murai, M Ikeda

PMCID: PMC489222 PMID: 1527554

738

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
Osame M., Izumo S., Igata A., Matsumoto M., Matsumoto T., Sonoda S., Tara M., Shibata Y. Blood transfusion and HTLV-I associated myelopathy. Lancet. 1986 Jul 12;2(8498):104–105. doi: 10.1016/s0140-6736(86)91636-3. [DOI] [PubMed] [Google Scholar]
Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
Shibasaki H., Tokudome S., Kuroda Y., Yanagawa T., Yoshihara M. Prevalence of HTLV-I-associated myelopathy among HTLV-I carriers in Saga, Japan. Neuroepidemiology. 1989;8(3):124–127. doi: 10.1159/000110174. [DOI] [PubMed] [Google Scholar]
Whittemore A. S. Estimating attributable risk from case-control studies. Am J Epidemiol. 1983 Jan;117(1):76–85. doi: 10.1093/oxfordjournals.aje.a113518. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES